10.1111/j.1469-8137.2005.01598.x New Phytol
Important medical and regulatory considerations Peptides such as BPC-157 and CJC-1295/Ipamorelin are not standard first-line therapies
Email contact available for direct communication and individualized care planning
When this hormone binds to receptors in the brain, pancreas, stomach, and elsewhere, several things happen: Appetite is significantly reduced, with many patients reporting a dramatic decrease in food cravings Gastric emptying slows, meaning food stays in the stomach longer and fullness is sustained after smaller meals Blood sugar regulation improves, reducing the energy spikes and dips that typically drive overeating Interest in high-calorie and highly processed foods often reduces, an effect many patients describe as the food noise quietening Mounjaro (tirzepatide) adds a second mechanism by also activating the GIP receptor
Edited by Alessandro Finazzi-Agr Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
